| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -19.41B | 3.73B | 73.56B | 73.63B | 73.70B | 52.48B |
| Gross Profit | -374.61M | 1.33B | 8.48B | 11.31B | 13.50B | 11.66B |
| EBITDA | 866.73M | 925.81M | 4.62B | 7.04B | 8.90B | 7.78B |
| Net Income | -2.13B | -2.06B | 913.58M | 1.73B | 3.74B | 4.33B |
Balance Sheet | ||||||
| Total Assets | 9.49B | 9.72B | 201.58B | 251.94B | 288.52B | 283.75B |
| Cash, Cash Equivalents and Short-Term Investments | 838.59M | 1.03B | 17.65B | 27.93B | 36.84B | 33.26B |
| Total Debt | 216.80M | 833.67M | 38.17B | 48.61B | 56.55B | 58.88B |
| Total Liabilities | 4.51B | 4.64B | 151.46B | 201.62B | 240.71B | 243.54B |
| Stockholders Equity | 4.84B | 4.90B | 25.31B | 24.86B | 23.51B | 22.07B |
Cash Flow | ||||||
| Free Cash Flow | 1.55B | -2.37B | 3.43B | 2.84B | 3.05B | -2.08B |
| Operating Cash Flow | 1.59B | -2.26B | 3.63B | 3.04B | 3.21B | -2.03B |
| Investing Cash Flow | -14.30B | -14.25B | 4.65B | 5.38B | 3.44B | -7.25B |
| Financing Cash Flow | 2.32B | -6.04M | -12.58B | -12.95B | 1.06B | 8.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.39B | 4.67 | 15.52% | 4.43% | 6.54% | 3.26% | |
71 Outperform | HK$3.89B | 9.48 | 18.70% | 5.77% | -7.78% | -29.31% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
53 Neutral | HK$2.84B | 19.47 | 3.94% | 11.14% | -1.14% | ― | |
51 Neutral | HK$12.43B | 11.52 | 74.40% | ― | 4.74% | -21.33% | |
45 Neutral | HK$5.05B | 4.29 | ― | 10.24% | ― | ― |